Acute tubulo-interstitial nephritis and renal infarction secondary to ergotamine therapy.
Janssen van Doorn
K
K
Department of Internal Medicine, Vrije Universiteit Brussel, Brussels, Belgium.
Van der Niepen
P
P
van Tussenbroeck
F
F
Verbeelen
D
D
D000959:Antihypertensive Agents / Q000627:therapeutic use; D001706:Biopsy; D004878:Ergotamine / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology; D007238:Infarction / Q000139:chemically induced* / Q000150:complications / Q000473:pathology; D007668:Kidney / Q000098:blood supply* / Q000473:pathology; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D009395:Nephritis, Interstitial / Q000139:chemically induced* / Q000150:complications / Q000473:pathology; D011859:Radiography; D012077:Renal Artery / Q000000981:diagnostic imaging; D012078:Renal Artery Obstruction / Q000139:chemically induced* / Q000000981:diagnostic imaging; D013488:Suppositories; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000009:adverse effects
D000959:Antihypertensive Agents; D013488:Suppositories; D014662:Vasoconstrictor Agents; D004878:Ergotamine